Douglas R Farquhar1, April M Tanner2, Maheer M Masood2, Sagar R Patel2, Trevor G Hackman2, Andrew F Olshan3, Angela L Mazul4, Jose P Zevallos5. 1. Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States. Electronic address: Douglas.Farquhar@unchealth.unc.edu. 2. Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States. 3. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. 4. Department of Otolaryngology-Head and Neck Surgery, Washington University, St. Louis, MO, United States. 5. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Otolaryngology-Head and Neck Surgery, Washington University, St. Louis, MO, United States.
Abstract
INTRODUCTION: The incidence of oral tongue squamous cell carcinoma (OTSCC) in younger adults has rapidly increased over the past two decades. While tobacco and alcohol use may be less likely to cause these tumors, it remains controversial whether differences also exist in their prognosis. Our aim is to examine the risk factors for cancer among young (<45 years old) OTSCC patients at our institution, and to compare their recurrence and survival with older patients in a matched cohort. MATERIALS AND METHODS: All OTSCC patients seen at our institution between 2000 and 2015 were reviewed. Patients under 45 who with sufficient treatment information were matched 1:1 on race, T-stage, and N-stage with patients 45 and older. Three-year recurrence and survival were determined in stratified and adjusted Cox regression models. RESULTS: Of 397 OTSCC patients were seen at our institution, 117 (29%) were less than 45 years old. Younger patients were significantly more likely to be female, (50% vs. 39%; p = 0.04) and to abstain from tobacco (51% vs. 39%; p < 0.01). Young patients in the matched cohort were significantly more likely to have a recurrence (HR 3.9 95% CI 1.4-10.5). There was no difference in overall survival. CONCLUSION: Younger OTSCC patients in a matched cohort were more likely to recur within 3 years, although there was no difference in overall mortality. Differences in risk factors and recurrence between older and younger patients suggest that some cancer among younger patients may be distinct from traditional OTSCC.
INTRODUCTION: The incidence of oral tongue squamous cell carcinoma (OTSCC) in younger adults has rapidly increased over the past two decades. While tobacco and alcohol use may be less likely to cause these tumors, it remains controversial whether differences also exist in their prognosis. Our aim is to examine the risk factors for cancer among young (<45 years old) OTSCC patients at our institution, and to compare their recurrence and survival with older patients in a matched cohort. MATERIALS AND METHODS: All OTSCC patients seen at our institution between 2000 and 2015 were reviewed. Patients under 45 who with sufficient treatment information were matched 1:1 on race, T-stage, and N-stage with patients 45 and older. Three-year recurrence and survival were determined in stratified and adjusted Cox regression models. RESULTS: Of 397 OTSCC patients were seen at our institution, 117 (29%) were less than 45 years old. Younger patients were significantly more likely to be female, (50% vs. 39%; p = 0.04) and to abstain from tobacco (51% vs. 39%; p < 0.01). Young patients in the matched cohort were significantly more likely to have a recurrence (HR 3.9 95% CI 1.4-10.5). There was no difference in overall survival. CONCLUSION: Younger OTSCC patients in a matched cohort were more likely to recur within 3 years, although there was no difference in overall mortality. Differences in risk factors and recurrence between older and younger patients suggest that some cancer among younger patients may be distinct from traditional OTSCC.
Authors: Melina Windon; Carole Fakhry; Lisa Rooper; Patrick Ha; David Schoppy; Brett Miles; Wayne Koch; Peter Vosler; David Eisele; Gypsyamber D'Souza Journal: Otolaryngol Head Neck Surg Date: 2020-06-23 Impact factor: 3.497
Authors: Rafael Ferreira E Costa; Marina Luiza Baião Leão; Maria Sissa Pereira Sant'Ana; Ricardo Alves Mesquita; Ricardo Santiago Gomez; Alan Roger Santos-Silva; Syed Ali Khurram; Artysha Tailor; Ciska-Mari Schouwstra; Liam Robinson; Willie F P van Heerden; Ramiro Alejandro Tomasi; Romina Gorrino; Ruth Salomé Ferreyra de Prato; Adalberto Mosqueda Taylor; José Manuel Aguirre Urizar; Irene Lafuente Ibañez de Mendoza; Raghu Radhakrishnan; Chetana Chandrashekar; Siu-Wai Choi; Peter Thomson; Hélder Antônio Rebelo Pontes; Felipe Paiva Fonseca Journal: Head Neck Pathol Date: 2022-03-22
Authors: Sophie Deneuve; Joanne Guerlain; Agnès Dupret-Bories; Claire Majoufre; Pierre Philouze; Philippe Ceruse; Marion Perreard; Nicolas Sigaud; Béatrix Barry; Pierre Ransy; Philippe Schultz; Olivier Malard; Sylvain Morinière; Anne Chatellier; Erwan De Monès; Mireille Folia; François Virard; Béatrice Fervers Journal: Eur Arch Otorhinolaryngol Date: 2021-04-20 Impact factor: 2.503
Authors: Marta Tagliabue; Pietro Belloni; Rita De Berardinis; Sara Gandini; Francesco Chu; Stefano Zorzi; Caterina Fumagalli; Luigi Santoro; Susanna Chiocca; Mohssen Ansarin Journal: Cancer Med Date: 2021-03-24 Impact factor: 4.452
Authors: Michael T Brennan; Nathaniel S Treister; Thomas P Sollecito; Brian L Schmidt; Lauren L Patton; Yi Yang; Alexander Lin; Linda S Elting; James S Hodges; Rajesh V Lalla Journal: Head Neck Date: 2020-09-29 Impact factor: 3.147